3D MEDICINES 01244Hong Kong Stock Exchange

2.3903.46%( +0.080 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
3D MEDICINES (01244) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2022-12-15
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG8872R1011

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)417.57M71/112
Net Profit (Last FY)-208.18M78/125
ROE (Last FY)-29.75%88/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Gong Zhaolong Executive Director
Zhou Feng Non-Executive Director
Chen Yawen Non-Executive Director
Zhang Wenhua Non-Executive Director
Li Jin Independent Non-Executive Director
Lin Tat Pang Independent Non-Executive Director
Liu Xinguang Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-07.

About this page

This page shows 3D MEDICINES (01244) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.